Atrion Corporation Inc. (ATRI) - Long-Term Liabilities to Capital

Historical price action for Atrion Corporation (ATRI) allows for an assessment of the brand's resilience as a creator of benchmark instruments for ophthalmology and cardiac surgery. The business relies on the production of critical components for hospital infusion systems. Flawless risk management by leadership has ensured a debt-free status, with the current indicator standing at 0.00, confirming the company's financial discipline and the premium positioning of its products.

The ratio is calculated as the proportion of liabilities with a maturity of more than one year to total equity. This metric determines the extent to which long-term financing depends on shareholders' funds, thereby assessing financial stability. For Atrion Corporation (ATRI), the balance of borrowed capital is critical when upgrading its technological base. By analyzing the long-term debt-to-equity trend, an investor can identify the risk of excessive leverage. An optimal ratio ensures expansion in medtech markets without the threat of bankruptcy.